We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-2.36%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$46.8B
AUM Growth
-$2.48B
(-5%)
Cap. Flow
-$831M
Cap. Flow
% of AUM
-1.77%
Top 10 Holdings %
Top 10 Hldgs %
28.11%
Holding
1,786
New
25
Increased
394
Reduced
504
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$130M |
| 2 |
Amgen
AMGN
|
+$96.1M |
| 3 |
Progressive
PGR
|
+$94.9M |
| 4 |
AbbVie
ABBV
|
+$77.1M |
| 5 |
Kenvue
KVUE
|
+$75.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$148M |
| 2 |
Johnson & Johnson
JNJ
|
+$147M |
| 3 |
LyondellBasell Industries
LYB
|
+$108M |
| 4 |
Dollar General
DG
|
+$91.2M |
| 5 |
ExxonMobil
XOM
|
+$87.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.48% |
| 2 | Healthcare | 17.42% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 9.71% |
| 5 | Communication Services | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
argenx
ARGX
$54.6B
| $11.6M | 0.02% |
23,589
-154
| -0.6% | -$75.3K |
|
352
Teradyne
TER
$50.2B
| $11.5M | 0.02% |
114,970
+23,003
| +25% | +$2.43M |
|
353
Sempra
SRE
$59.2B
| $11.5M | 0.02% |
168,961
+31,905
| +23% | +$2.3M |
|
354
Cognex
CGNX
$10B
| $11.5M | 0.02% |
270,731
-271,768
| -50% | -$13.4M |
|
355
Host Hotels & Resorts
HST
$17.4B
| $11.5M | 0.02% |
712,731
+390,308
| +121% | +$6.5M |
|
356
Crinetics Pharmaceuticals
CRNX
$8.88B
| $11.4M | 0.02% |
384,685
+114,416
| +42% | +$2.36M |
|
357
Zoom
ZM
$26.8B
| $11.4M | 0.02% |
162,619
+93,680
| +136% | +$6.5M |
|
358
WillScot Mobile Mini Holdings
WSC
$4.66B
| $11.4M | 0.02% |
273,350
-6,793
| -2% | -$299K |
|
359
Alkermes
ALKS
$8.42B
| $11.3M | 0.02% |
402,771
-9,519
| -2% | -$279K |
|
360
Veeva Systems
VEEV
$32.7B
| $11.2M | 0.02% |
55,045
-4,639
| -8% | -$935K |
|
361
Albemarle
ALB
$13.3B
| $11.2M | 0.02% |
65,691
-21,368
| -25% | -$4.26M |
|
362
General Dynamics
GD
$106B
| $11.2M | 0.02% |
50,496
-25,120
| -33% | -$5.56M |
|
363
Cboe Global Markets
CBOE
$31.1B
| $11.1M | 0.02% |
71,192
-2,844
| -4% | -$418K |
|
364
Vulcan Materials
VMC
$37.4B
| $11.1M | 0.02% |
54,850
-121,441
| -69% | -$26.4M |
|
365
American Water Works
AWK
$27B
| $11.1M | 0.02% |
89,445
+13,310
| +17% | +$1.87M |
|
366
Everest Group
EG
$15.8B
| $11M | 0.02% |
29,697
+3,243
| +12% | +$1.18M |
|
367
TE Connectivity
TEL
$62.1B
| $11M | 0.02% |
89,230
-5,808
| -6% | -$776K |
|
368
W.R. Berkley
WRB
$28.3B
| $11M | 0.02% |
260,213
+40,662
| +19% | +$1.68M |
|
369
Citizens Financial Group
CFG
$30.8B
| $11M | 0.02% |
410,698
+133,571
| +48% | +$3.82M |
|
370
Pultegroup
PHM
$25.7B
| $11M | 0.02% |
148,583
+19,828
| +15% | +$1.58M |
|
371
T. Rowe Price
TROW
$26.1B
| $10.9M | 0.02% |
104,282
-20,567
| -16% | -$2.32M |
|
372
F5
FFIV
$22.8B
| $10.7M | 0.02% |
66,429
+1,773
| +3% | +$277K |
|
373
GE HealthCare
GEHC
$29.2B
| $10.6M | 0.02% |
156,481
+606
| +0.4% | +$44.1K |
|
374
Incyte
INCY
$26B
| $10.6M | 0.02% |
183,928
+20,389
| +12% | +$1.29M |
|
375
BioMarin Pharmaceuticals
BMRN
$12B
| $10.6M | 0.02% |
119,881
-2,070
| -2% | -$184K |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Ensign Peak Advisors held 1,786 positions worth $46.8B, down 5% from $49.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 3.1%. Ensign Peak Advisors opened 25 new positions and exited 30, leaving the 1,786-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2023 buy was Invesco QQQ Trust: 160,000 shares worth $57.3M.
- Ensign Peak Advisors added most to Crown Castle in Q3 2023, an estimated $130M increase.
- Ensign Peak Advisors's biggest Q3 2023 reduction was Eli Lilly, cutting an estimated $148M.
- Ensign Peak Advisors fully exited RB Global in Q3 2023, selling an estimated $26.5M.
- Ensign Peak Advisors's ten largest holdings make up 28% of its $46.8B portfolio in Q3 2023.
- Ensign Peak Advisors opened 25 new positions and closed 30 in Q3 2023.
- Ensign Peak Advisors's portfolio value fell 5% quarter-over-quarter to $46.8B.
Based on Ensign Peak Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.